Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients
Effects of Wearable Vibratory Devices for Upper Limb Function Among Subacute Hemiplegic Patients: A Randomized Controlled Trial
University of Faisalabad
30 participants
Feb 1, 2026
INTERVENTIONAL
Conditions
Summary
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Eligibility
Inclusion Criteria5
- Unilateral hemiplegia secondary to stroke
- Age between 30 and 60 years
- Subacute stage (3 to 6 months post-stroke)
- Fugl-Meyer Assessment (FMA) score between 20 and 50
- Able to follow simple verbal commands
Exclusion Criteria5
- Previous peripheral nerve injury or surgery affecting the upper limb
- Fixed contractures or bony fractures in the affected limb
- Complete sensory loss of the upper limb
- Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia)
- Unstable cardiovascular conditions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A portable, battery-operated device worn on the forearm. It delivers high-frequency focal vibration (100-120 Hz) to the muscle belly (biceps/forearm extensors) to reduce spasticity and facilitate motor recruitment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07641790